3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists.
Wang Y, Busch-Petersen J, Wang F, Ma L, Fu W, Kerns JK, Jin J, Palovich MR, Shen JK, Burman M, Foley JJ, Schmidt DB, Hunsberger GE, Sarau HM, Widdowson KL.
Wang Y, et al. Among authors: fu w.
Bioorg Med Chem Lett. 2007 Jul 15;17(14):3864-7. doi: 10.1016/j.bmcl.2007.05.011. Epub 2007 May 10.
Bioorg Med Chem Lett. 2007.
PMID: 17524641